Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Hubei Jumpcan Pharmaceutical Co Ltd cash flow reinvestment rate. Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Cash Flow Reinvestment Rate of 5.41x as of June 2025, reinvesting CN¥966.92 Million (capex CN¥15.27 Million plus investments CN¥-951.65 Million) from operating cash flow of CN¥178.57 Million. Explore Hubei Jumpcan Pharmaceutical Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
Cash flow reinvestment rate of Hubei Jumpcan Pharmaceutical Co Ltd from 2000 to 2025. Historical reinvestment intensity for Hubei Jumpcan Pharmaceutical Co Ltd across 25 annual periods. Explore how much does Hubei Jumpcan Pharmaceutical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2000–2025)
Hubei Jumpcan Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2000 to 2025. Year-by-year capital reinvestment analysis for Hubei Jumpcan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Hubei Jumpcan Pharmaceutical Co Ltd (600566) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥976.87 Million | CN¥1.20 Billion | CN¥95.86 Million | ▼ -13.1% |
| 2024 | 0.94x | CN¥2.04 Billion | CN¥2.18 Billion | CN¥174.34 Million | ▲ +366.7% |
| 2023 | 0.20x | CN¥695.87 Million | CN¥3.46 Billion | CN¥301.64 Million | ▼ -67.6% |
| 2022 | 0.62x | CN¥1.62 Billion | CN¥2.62 Billion | CN¥243.66 Million | ▲ +62.3% |
| 2021 | 0.38x | CN¥723.21 Million | CN¥1.89 Billion | CN¥248.32 Million | ▼ -55.4% |
| 2020 | 0.86x | CN¥1.53 Billion | CN¥1.78 Billion | CN¥429.63 Million | ▲ +189.4% |
| 2019 | 0.30x | CN¥635.44 Million | CN¥2.15 Billion | CN¥546.44 Million | ▼ -51.1% |
| 2018 | 0.61x | CN¥1.03 Billion | CN¥1.71 Billion | CN¥668.06 Million | ▼ -40.5% |
| 2017 | 1.02x | CN¥1.21 Billion | CN¥1.19 Billion | CN¥746.25 Million | ▲ +106.5% |
| 2016 | 0.49x | CN¥449.49 Million | CN¥913.10 Million | CN¥323.49 Million | ▼ -41.8% |
| 2015 | 0.85x | CN¥545.98 Million | CN¥645.48 Million | CN¥395.98 Million | ▲ +72.8% |
| 2014 | 0.49x | CN¥301.51 Million | CN¥616.11 Million | CN¥301.51 Million | ▼ -48.0% |
| 2013 | 0.94x | CN¥270.10 Million | CN¥287.16 Million | CN¥270.10 Million | ▼ -43.1% |
| 2012 | 1.65x | CN¥44.67 Million | CN¥27.01 Million | CN¥44.67 Million | ▼ -98.9% |
| 2011 | 147.69x | CN¥60.74 Million | CN¥411.24K | CN¥60.74 Million | ▲ +9770.9% |
| 2010 | 1.50x | CN¥76.50 Million | CN¥51.13 Million | CN¥76.50 Million | ▲ +2.4% |
| 2009 | 1.46x | CN¥7.19 Million | CN¥4.92 Million | CN¥7.19 Million | ▲ +304.4% |
| 2008 | 0.36x | CN¥8.33 Million | CN¥23.05 Million | CN¥8.33 Million | ▲ +69.4% |
| 2007 | 0.21x | CN¥7.83 Million | CN¥36.72 Million | CN¥7.83 Million | ▼ -98.3% |
| 2006 | 12.22x | CN¥51.83 Million | CN¥4.24 Million | CN¥51.83 Million | ▲ +1194.8% |
| 2005 | 0.94x | CN¥59.80 Million | CN¥63.38 Million | CN¥59.80 Million | ▼ -94.7% |
| 2003 | 17.83x | CN¥39.99 Million | CN¥2.24 Million | CN¥39.99 Million | ▲ +235.0% |
| 2002 | 5.32x | CN¥117.09 Million | CN¥22.00 Million | CN¥117.09 Million | ▼ -55.1% |
| 2001 | 11.86x | CN¥88.07 Million | CN¥7.43 Million | CN¥88.07 Million | ▲ +1349.6% |
| 2000 | 0.82x | CN¥19.41 Million | CN¥23.73 Million | CN¥19.41 Million | — |